57.09 0.00 (0.00%)
After hours: 4:41PM EDT
|Bid||57.05 x 1100|
|Ask||57.61 x 1800|
|Day's Range||56.68 - 57.19|
|52 Week Range||33.93 - 59.40|
|Beta (3Y Monthly)||0.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 2, 2019|
|Forward Dividend & Yield||0.35 (0.61%)|
|1y Target Est||59.00|
Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.
CHARLOTTE, N.C., July 11, 2019 -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and.
DENTSPLY SIRONA Inc NASDAQ/NGS:XRAYView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for XRAY with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting XRAY. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.98 billion over the last one-month into ETFs that hold XRAY are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Monday started with a jolt for investors in the pharmaceutical distributor, which announced in a regulatory filing that longtime Chief Financial Officer Jorge Gomez is leaving the company.
Dental products maker Dentsply Sirona Inc. said Monday it has appointed Jorge Gomez, former chief financial officer of Cardinal Health Inc. as its CFO. The announcement came shortly after Cardinal Health said Gomez was leaving on Aug. 9. Dentsply shares were not active premarket, but have gained 55% in 2019, while the S&P 500 has gained 19.3%.
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), the Dental Solutions Company, today announced the appointment of Jorge M. Gomez as Chief Financial Officer. Jorge M. Gomez served as Chief Financial Officer of Cardinal Health since January 2018, where he was responsible for financial activities across the enterprise, including financial strategy, capital deployment, treasury, investor relations, tax, accounting and external reporting. Prior to that, Jorge was Chief Financial Officer of the Medical and Pharmaceutical segments, and Treasurer and Corporate Controller at Cardinal Health. Before joining Cardinal Health, Jorge held multiple executive and leadership roles at General Motors and the Smurfit-Kappa Group. "On behalf of the entire management team, I would like to extend a warm welcome to Jorge Gomez. He is a talented global executive with an in-depth knowledge of the healthcare market, who brings the right mix of skills and experience, and a solid track record of successfully managing global finance operations,” said Don Casey, Dentsply Sirona’s CEO.
With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.
Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.
Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.
Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.
The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.
Varian (VAR) expects the Cancer Treatment Services International buyout to prove accretive to earnings per share during fiscal 2021.
Patterson Companies' (PDCO) Q4 results benefit from higher revenues, gross margin expansion and solid show by Animal Health segment.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc. New York, June 24, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.